ArticleOncogene2025

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model.

Runa Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.